Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Tax Provisions (2017 - 2021)

Historic Tax Provisions for Celldex Therapeutics (CLDX) over the last 4 years, with Q3 2021 value amounting to -$227000.0.

  • Celldex Therapeutics' Tax Provisions changed N/A to -$227000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was -$1.2 million, marking a year-over-year increase of 8.57%. This contributed to the annual value of -$227000.0 for FY2021, which is 8054.84% up from last year.
  • Celldex Therapeutics' Tax Provisions amounted to -$227000.0 in Q3 2021.
  • In the past 5 years, Celldex Therapeutics' Tax Provisions ranged from a high of -$227000.0 in Q3 2021 and a low of -$19.1 million during Q4 2017
  • In the last 4 years, Celldex Therapeutics' Tax Provisions had a median value of -$852000.0 in 2018 and averaged -$4.4 million.